Bayer Consumer Care AG

• A study to learn more about the change in the blood levels of transthyretin when participants with transthyretin amyloidosis with cardiomyop… Recruiting
  2025-521831-35-00 Phase IV 4 countries ACORAMIDIS
• A first-in-human study to learn about the safety of BAY 3547926 and how well it works in participants with advanced liver cancer Recruiting
  2024-516615-25-00 Phase I 4 countries
• A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so… Recruiting
  2024-517419-62-00 Phase II 4 countries 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,…
• First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCR… Recruiting
  2023-507486-26-00 Phase I 5 countries
• A study to compare the study treatment darolutamide in combination with androgen deprivation therapy (ADT) to placebo in combination with AD… Ended
  2022-501343-33-00 Phase III 14 countries DAROLUTAMIDE; GALLIUM (68GA) GOZETOTIDE; PIFLUFOLASTAT (18F)
• A study to learn more about how well elinzanetant works and how safe it is compared to placebo for the treatment of hot flashes caused by an… Ended
  2023-508265-33-00 Phase III 12 countries ELINZANETANT
• An open study for participants who have been on darolutamide treatment in any other Bayer study Ended
  2022-502084-38-00 Phase III 17 countries DAROLUTAMIDE
• Investigation of Radium-223 dichloride (Xofigo), a treatment that gives off radiation that helps kill cancer cells, compared to a treatment … Ended
  2023-505830-89-00 Phase IV 10 countries ABIRATERONE ACETATE; ENZALUTAMIDE; PREDNISOLONE; PREDNISONE; RADIUM RA 223 DICHL…
• A study to test the safety and efficacy of the drug larotrectinib for the treatment of tumors with NTRK-fusion in children Ended
  2022-502668-20-00 Phase I/II 9 countries LAROTRECTINIB SULFATE
• A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause Ended
  2023-504955-28-01 Phase II 7 countries ELINZANETANT
• A study to learn about how much elinzanetant gets absorbed in the blood and how safe it is in healthy participants when taken as different t… Ended
  2023-503968-16-00 Phase I (Other) 1 country ELINZANETANT
• A study to learn how much elinzanetant gets into the blood, how safe it is and how it affects the body after taking single and multiple amou… Ended
  2023-503864-17-00 Phase I (Other) 1 country
• A Phase 3 safety study of BAY 94-9027 in children 7 to <12 years of age with severe hemophilia A Ended
  2023-504388-18-00 Phase III 2 countries DAMOCTOCOG ALFA PEGOL
• A study to learn how the study drug elinzanetant (BAY 3427080) affects the way the drug dabigatran moves into, through and out of the body i… Ended
  2022-500201-41-00 Phase I (Other) 1 country DABIGATRAN ETEXILATE; ELINZANETANT
• A trial to learn how well darolutamide plus androgen deprivation therapy (ADT) works in comparison to placebo plus ADT in men with prostate … Ended
  2022-502244-12-00 Phase III 3 countries DAROLUTAMIDE
• A study to assess how radium-223 moves through the patients with prostate cancer receiving radium-223 dichloride treatment. Ended
  2023-506435-15-00 Phase I (Other) 4 countries
• "A study to learn how well the drug larotrectinib works in adults with different solid cancers with a change in the genes called NTRK fusion… Ended
  2022-502667-38-00 Phase II 6 countries LAROTRECTINIB SULFATE

Showing 1–17 of 17 trials